SCHEMBL6620544

SCHEMBL6620544

O=C1N[C@H]2CCN(C(=O)OCc3ccccc3)C2=C1C1CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 2/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTR2C P28335 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
JAK2 O60674 2/20 0.41
JAK1 P23458 2/20 0.41
TYK2 P29597 2/20 0.41
JAK3 P52333 2/20 0.41
GRIN2B Q13224 2/20 0.40
PARP1 P09874 1/20 0.39
FKBP1A P62942 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7406324 0.85 NPC1 (0.46) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6624131 0.84 NPC1 (0.45) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6618552 0.83 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL7989218 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6619994 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6617554 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6618031 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6619041 0.81 ELANE (0.43) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL6621891 0.81 ELANE (0.43) NPC1RAB9ASMN1; SMN2L3MBTL1GAA
SCHEMBL7405713 0.75 NPC1 (0.48) NPC1RAB9ASMN1; SMN2L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891362-B1 PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE GLAXO GROUP LTD (GB) 2004-03-17 EP disclosed
US-6215002-B1 CYCLIZATION, DEBLOCKING, DEPROTECTION, SULFONATION, CONDENSATION, AMIDATION; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS GLAXO WELLCOME INC. 2001-04-10 US disclosed
US-6057457-A ENZYME INHIBITORS FOR PROTEASE OR ENZYMES OF HYDROLYSIS GLAXO WELLCOME INC. (US) 2000-05-02 US disclosed
US-5994344-A BRONCHITIS THERAPY GLAXO WELLCOME INC. (US) 1999-11-30 US disclosed